Dyne Therapeutics (DYN) Research & Development (2019 - 2026)

Dyne Therapeutics' Research & Development history runs 8 years deep, the most recent figure standing at $100.9 million for Q1 2026.

• In Q1 2026, Research & Development fell 5.22% year-over-year to $100.9 million; the TTM figure through Mar 2026 stood at $392.8 million (up 14.41% YoY), while the FY2025 annual figure was $398.3 million, up 41.55% from the prior year.
• Research & Development was $100.9 million for Q1 2026 at Dyne Therapeutics, up from $95.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $106.4 million in Q1 2025 to a low of $28.2 million in Q1 2022.
• Historically, Research & Development has averaged $66.7 million across 5 years, with a median of $59.1 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Research & Development decreased 21.54% in 2022, then soared 139.0% in 2025.
• A 5-year view of Research & Development shows it stood at $33.2 million in 2022, then soared by 77.29% to $58.8 million in 2023, then soared by 39.02% to $81.8 million in 2024, then climbed by 16.66% to $95.4 million in 2025, then advanced by 5.72% to $100.9 million in 2026.
• The last three Research & Development figures came in at $100.9 million (Q1 2026), $95.4 million (Q4 2025), and $97.2 million (Q3 2025), per Business Quant data.